Skip To Content
JEWISH. INDEPENDENT. NONPROFIT.
Fast Forward

4th coronavirus shot increased antibodies fivefold, preliminary data from Israel shows

(JTA) — A fourth dose of the coronavirus vaccine increases antibodies fivefold in patients who receive the shots, preliminary findings from an Israeli study show.

Israel’s Prime Minister Naftali Bennett announced the news at the Sheba Medical Center near Tel Aviv on Tuesday, alongside Dr. Gili Regev-Yochay, a lead researcher on the study. The results have not been peer reviewed.

“We know that a week after administration of a fourth dose, we see a five-fold increase in the number of antibodies in the vaccinated person,” Bennett said, according to Haaretz. “This most likely means a significant increase against infection and …hospitalization and [severe] symptoms.”

Israel began administering fourth doses of the coronavirus vaccine this week as a second booster shot to adults ages 60 and up, as well as medical workers who have gone at least four months since their first booster shot. Nearly 100,000 people already received or were scheduled to receive a fourth dose of the coronavirus vaccine as of Tuesday, The Times of Israel reported.

The World Health Organization, Dr. Anthony Fauci and others have expressed concern about the aggressive booster program.

Professor Galia Rahav, the head of Sheba’s infectious diseases center, spoke to an Israeli news channel to address the criticism on Tuesday.

“We’re always ahead of the rest. That’s been the case the whole way. We learned a lot about the third shot before the rest. And we saw its amazing effect — reducing illness in the most impressive way,” Rahav told Channel 12, according to The Times of Israel.


The post 4th coronavirus shot increased antibodies fivefold, preliminary data from Israel shows appeared first on Jewish Telegraphic Agency.

A message from our CEO & publisher Rachel Fishman Feddersen

I hope you appreciated this article. Before you go, I’d like to ask you to please support the Forward’s award-winning, nonprofit journalism during this critical time.

At a time when other newsrooms are closing or cutting back, the Forward has removed its paywall and invested additional resources to report on the ground from Israel and around the U.S. on the impact of the war, rising antisemitism and polarized discourse..

Readers like you make it all possible. Support our work by becoming a Forward Member and connect with our journalism and your community.

—  Rachel Fishman Feddersen, Publisher and CEO

Join our mission to tell the Jewish story fully and fairly.

Republish This Story

Please read before republishing

We’re happy to make this story available to republish for free, unless it originated with JTA, Haaretz or another publication (as indicated on the article) and as long as you follow our guidelines. You must credit the Forward, retain our pixel and preserve our canonical link in Google search.  See our full guidelines for more information, and this guide for detail about canonical URLs.

To republish, copy the HTML by clicking on the yellow button to the right; it includes our tracking pixel, all paragraph styles and hyperlinks, the author byline and credit to the Forward. It does not include images; to avoid copyright violations, you must add them manually, following our guidelines. Please email us at editorial@forward.com, subject line “republish,” with any questions or to let us know what stories you’re picking up.

We don't support Internet Explorer

Please use Chrome, Safari, Firefox, or Edge to view this site.

Exit mobile version